OVARIAN CANCER

Health, will be right recurrent ovarian cancer surgery and chemotherapy again whether there has been significant controversy. Fourth Military Medical University Xijing Hospital director of obstetrics and gynecology professor Detang, has nearly 10 years of the 38 treated patients with recurrent epithelial ovarian cancer clinical data were analyzed retrospectively after that, again recurrent ovarian cancer surgery and chemotherapy, can further improve the survival rate of patients.

Tags: cancer, cases, chemotherapy, clinical, early, eat, ovarian, patients, rate, surgery, survival, therapy, treatment, tumor, tumors

A scholar from the Netherlands led multinational collaborative research suggest that the early epithelial ovarian cancer surgical staging, can predict whether the patients have residual ovarian cancer and the need for postoperative adjuvant chemotherapy.

Tags: age, cancer, carcinoma, cases, cell, chemotherapy, cisplatin, clinical, early, examination, group, ovarian, patients, poor, prognosis, rate, residual, staging, surgery, surgical, survival, therapy, time, tumor

【Medical industry network HealthDayNews2003 According to the July 3 - now on the younger female epithelial ovarian cancer, some important information: your chances of survival much more than older patients.

In July, "Obstetrics and Gynecology" (Obstetrics andGynecology), the journal published a new study, the researchers found: diagnosis of advanced epithelial ovarian cancer in women aged under 45 of the 5-year survival than those over the age of 45 is two times bigger. "If all other aspects of the same, young patients can live better," the author, Stamford University professor Chen (JohnChan): In fact, even if it is possible to study the impact of factors, such as other health problems, age patients still live better.

Tags: age, blood, cancer, clinical, diagnosis, early, gene, group, groups, growth, method, ovarian, patients, positive, rate, response, study, surgery, survival, time, tumor, women

Denmark Gronloud such report, as paclitaxel plus platinum chemotherapy after complete remission in patients with ovarian cancer, if recurrence of a solitary lesion again cytoreductive surgery may improve survival. (Eur J Surg Oncol 2005,31:67)

In the retrospective study selected criteria: 1 Guide to the residual initial stage operation and confirmed by histological examination of epithelial ovarian cancer; (2) complete remission after first-line treatment; 3. Imaging confirmed pots peritoneal metastasis; (4) Surgical resection of lesions for the purpose.

Tags: age, cancer, cases, cell, chemotherapy, eat, examination, metastasis, ovarian, paclitaxel, patients, rate, resection, residual, study, surgery, surgical, survival, therapy, time, treatment, tumor, tumors

In recent decades, the treatment of gynecologic cancer progress has been made, but only the ovarian cancer there is no significant improvement. The incidence of ovarian cancer Habitat Gynecologic Oncology third, but it was the first fatality rate. Its cause high mortality due to the growth of ovarian cancer site concealment, not be seen directly, patients still in the early stages of the lack of simple and practical method of diagnosis. Most (about 70%) have been newly diagnosed patients with peritoneal metastasis pots. Currently taken by surgery, radiotherapy, chemotherapy and immunotherapy for the treatment of Chinese medicine integrated with the right therapy, in the treatment of advanced worse still, it is difficult to avoid recurrence. But by early diagnosis and treatment of patients with ovarian cancer prognosis is quite different. Case in epithelial ovarian cancer, according to statistics, the five-year survival rate, 80% for stage I, 40% for Stage II; While Ⅲ period just below 5%. Visibility early detection, early diagnosis and treatment of patients with ovarian cancer is a lifetime event.

Tags: abdominal, age, annex, anti, bleeding, cancer, carcinoma, cases, cause, chemotherapy, clinical, cyst, cystic, diagnosis, diet, early, eat, ert, examination, family, fat, growth, gynecological, history, incidence, increased, life, malignant, mass, metastasis, method, oppression, ovarian, pain, patients, pelvic, poor, prognosis, protein, quality, radiotherapy, rate, reduce, resection, surface, surgery, survival, symptoms, therapy, time, treatment, tumor, tumors, women

Treatment of ovarian cancer is still surgery and chemotherapy, although postoperative adjuvant systemic chemotherapy has been the effect certainly, but in some patients because of poor health and not systemic tolerance of the boil, and in some patients for fear of adverse reactions of chemotherapy automatically abandon further treatment, which greatly affects the quality of life and survival rate , an increase of ovarian cancer recurrence possible. The TCM adjuvant treatment of patients with chemotherapy can improve and the tolerance level of immunity and, therefore, Chinese medicine treatment of ovarian cancer has been more and more attention.

Tags: age, bleeding, cancer, cause, chemotherapy, cisplatin, clinical, drug, drugs, eat, ert, gene, injection, intravenous, knowledge, life, ovarian, patients, poor, prognosis, quality, rate, second, surgery, survival, symptoms, therapy, time, treatment, tumor, tumors

Serous cystadenoma
Zhu serous tumor of the kidney from the body cavity epithelium, is the most common tumors of the ovary. According to national statistics, the total of 2007-09-07 16:00:00.1% of ovarian tumors common in women aged 30-40. The unilateral nature, but there are also many of the bilateral. Simple solution can be divided into gland capsule and two papillary serous cystadenoma.

Tags: abdominal, age, amenorrhea, annex, anti, benign, bleeding, blood, body, breast, cancer, carcinoma, cases, cause, cell, cells, children, clinical, cyst, cystic, cysts, diagnosis, early, eat, ert, estrogen, gene, group, groups, growth, incidence, increased, malignant, mass, metastasis, metastatic, oppression, ovarian, ovary, patients, pelvic, poor, prognosis, protein, quality, radiation, rate, resection, surface, surgery, surgical, survival, symptoms, time, treatment, tumor, tumors, usually, uterine, women

A concept
Ovarian cysts are generalized on an ovarian tumor, all ages are sick, but the most aged 20-50. The prevalence of ovarian cancer rarely sick, so early diagnosis difficult, attendance at the 70% already advanced, little access to early treatment, five-year survival rate always hovering in the 20-30%, the threat to women's lives one of the most serious cancer, ovarian is smaller organ in the human body but for a good variety of tumor site, ovarian cancer can have a variety of nature and form - a single - or mixed type, or of the bilateral side, cystic or substantive, benign or malignant, and many women have ovarian tumors or male sex hormones.

Tags: abdominal, age, anti, benign, bleeding, body, cancer, cause, clinical, cyst, cystic, cysts, diagnosis, early, eat, eggs, ert, examination, gene, growth, gynecological, increased, malignant, mass, oppression, ovarian, pain, patients, pelvic, rate, second, survival, symptoms, treatment, tumor, tumors, usually, women

Ovarian cancer is the worst prognosis of gynecologic tumors. Patients with advanced epithelial ovarian cancer five-year survival rates generally below 30%, mainly in patients with relapsing most (about 75%), relapse after chemotherapy to poor results.

For the treatment of recurrent ovarian cancer chemotherapy drugs many, no less than 10 species, but only clinical remission rate of 20% to 30%, no progress median survival time (PFS) for 2 to 6 months, the median overall survival (OS) for six to 12 months. Therefore, to improve the efficacy of chemotherapy drugs delay, but the development of new drugs is very difficult, efficient use of existing drugs is an effective way to <BR>.

Tags: cancer, cases, chemotherapy, cisplatin, clinical, drug, drugs, early, eat, exploration, gene, group, method, ovarian, p53, paclitaxel, patients, pmtc, poor, positive, prognosis, rate, second, study, survival, taxol, therapy, time, treatment, tumor, tumors

Researchers reported that the joint use of both cisplatin and paclitaxel chemotherapy drug for ovarian cancer achieved better clinical remission rate and a higher survival rate, this new program has become advanced ovarian cancer patients with standard treatment programs.

From the European Organization for Cancer Research and Treatment of Dr Piccart, a group of researchers across the Atlantic to the two large-scale clinical trials group that cisplatin and paclitaxel (TP) both chemotherapy treatment of advanced ovarian cancer with significant advantages.

Tags: age, anti, cancer, chemotherapy, cisplatin, clinical, drug, eat, grams, group, history, ovarian, paclitaxel, patients, rate, study, survival, therapy, treatment, tumor, tumors